Home Healthcare Biotechnology Oncology Biosimilar Market

Oncology Biosimilar Market Size, Share & Trends Analysis Report By Product Type (Monoclonal Antibodies (mAbs), Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF), Immunomodulators), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Blood Cancer / Hematological Cancers, Other types (e.g., kidney, stomach, brain cancers)), By Route of Administration (Intravenous (IV), Subcutaneous (SC), Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 04, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Oncology Biosimilar Market Size Analysis
    1. Introduction
    2. Oncology Biosimilar Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies (mAbs)
      2. Hematopoietic Agents
      3. Granulocyte Colony-Stimulating Factor (G-CSF)
      4. Immunomodulators
    3. Oncology Biosimilar Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Cervical Cancer
      5. Blood Cancer / Hematological Cancers
      6. Other types (e.g., kidney, stomach, brain cancers)
    4. Oncology Biosimilar Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous (IV)
      2. Subcutaneous (SC)
      3. Others
    5. Oncology Biosimilar Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  7. North America Oncology Biosimilar Market Size Analysis
    1. Introduction
    2. Oncology Biosimilar Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies (mAbs)
      2. Hematopoietic Agents
      3. Granulocyte Colony-Stimulating Factor (G-CSF)
      4. Immunomodulators
    3. Oncology Biosimilar Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Cervical Cancer
      5. Blood Cancer / Hematological Cancers
      6. Other types (e.g., kidney, stomach, brain cancers)
    4. Oncology Biosimilar Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous (IV)
      2. Subcutaneous (SC)
      3. Others
    5. Oncology Biosimilar Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
  8. Europe Oncology Biosimilar Market Size Analysis
    1. Introduction
    2. Oncology Biosimilar Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies (mAbs)
      2. Hematopoietic Agents
      3. Granulocyte Colony-Stimulating Factor (G-CSF)
      4. Immunomodulators
    3. Oncology Biosimilar Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Cervical Cancer
      5. Blood Cancer / Hematological Cancers
      6. Other types (e.g., kidney, stomach, brain cancers)
    4. Oncology Biosimilar Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous (IV)
      2. Subcutaneous (SC)
      3. Others
    5. Oncology Biosimilar Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
  9. APAC Oncology Biosimilar Market Size Analysis
    1. Introduction
    2. Oncology Biosimilar Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies (mAbs)
      2. Hematopoietic Agents
      3. Granulocyte Colony-Stimulating Factor (G-CSF)
      4. Immunomodulators
    3. Oncology Biosimilar Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Cervical Cancer
      5. Blood Cancer / Hematological Cancers
      6. Other types (e.g., kidney, stomach, brain cancers)
    4. Oncology Biosimilar Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous (IV)
      2. Subcutaneous (SC)
      3. Others
    5. Oncology Biosimilar Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
  10. Middle East and Africa Oncology Biosimilar Market Size Analysis
    1. Introduction
    2. Oncology Biosimilar Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies (mAbs)
      2. Hematopoietic Agents
      3. Granulocyte Colony-Stimulating Factor (G-CSF)
      4. Immunomodulators
    3. Oncology Biosimilar Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Cervical Cancer
      5. Blood Cancer / Hematological Cancers
      6. Other types (e.g., kidney, stomach, brain cancers)
    4. Oncology Biosimilar Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous (IV)
      2. Subcutaneous (SC)
      3. Others
    5. Oncology Biosimilar Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
  11. LATAM Oncology Biosimilar Market Size Analysis
    1. Introduction
    2. Oncology Biosimilar Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies (mAbs)
      2. Hematopoietic Agents
      3. Granulocyte Colony-Stimulating Factor (G-CSF)
      4. Immunomodulators
    3. Oncology Biosimilar Market Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Cervical Cancer
      5. Blood Cancer / Hematological Cancers
      6. Other types (e.g., kidney, stomach, brain cancers)
    4. Oncology Biosimilar Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous (IV)
      2. Subcutaneous (SC)
      3. Others
    5. Oncology Biosimilar Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies (mAbs)
        2. Hematopoietic Agents
        3. Granulocyte Colony-Stimulating Factor (G-CSF)
        4. Immunomodulators
      3. Market Size & Forecast By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Cervical Cancer
        5. Blood Cancer / Hematological Cancers
        6. Other types (e.g., kidney, stomach, brain cancers)
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous (IV)
        2. Subcutaneous (SC)
        3. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
  12. Competitive Landscape
    1. Oncology Biosimilar Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Amgen Inc.
    3. Novartis International AG
    4. Biocon Ltd.
    5. Reddy’s Laboratories
    6. Samsung Bioepis
    7. Mylan N.V. (now part of Viatris)
    8. Allergan (AbbVie)
    9. STADA Arzneimittel AG
    10. Apotex Inc.
    11. Roche (via biosimilar affiliates)
    12. Sandoz (Novartis division)
    13. Celltrion Inc.
    14. Bio-Thera Solutions
    15. Organon (via acquired biosimilar rights)
    16. Teva Pharmaceuticals
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.